70
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Antitumor activity of novel pyrrolo[2,3-d]pyrimidin-4-ones

, , , &
Pages 271-276 | Received 12 Jun 2010, Accepted 01 Dec 2010, Published online: 07 Jun 2011

References

  • Abou El Ella, A. D., Ghorab, M. M., Noaman, E., Heiba, I. H., Khalil, I. A. (2007). Molecular modeling study and synthesis of novel pyrrolo[2,3-d]pyrimidines and pyrrolotriazolopyrimidines of expected antitumor and radioprotective activities. Bioorg Med Chem 16:2391–-2402.
  • Acs, G., Reich, E., Mori, M. (1964). Biological and biochemical properties of the analogue antibiotic, tubercidin. Proc Natl Acad Sci U S A 52:493–501.
  • Bazgir, A., Khanaposhtani, M. M., Soorki, A. A. (2008). One-pot synthesis and antibacterial activities of pyrazolo[4′,3′,5,6]pyrido[2,3-d]pyrimidine-dione derivatives. Bioorg Med Chem Lett 18:5800–5803.
  • Brohem, C. A., Sawada, T. C. H., Massaro, R. R., Almeida, R. L., Rivelli, D. P., Ropke, C. D., et al. (2009). Apoptosis induction by 4-nerolidylcatechol in melanoma cell lines. Toxicol In Vitro 23:111–119.
  • Calderwood, D. J., Johnson, D. N., Munschauer, R., Rafferty, P. (2002). Pyrrolo[2,3-d]pyrimidines containing diverse N-7 substituents as potent inhibitors of Lck. Bioorg Med Chem Lett 12:1683–1686.
  • Caldwell, J. J., Davies, T. G., Donald, A., McHardy, T., Rowlands, M. G., Aherne, G. W., et al. (2008). Identification of 4-4-aminopiperidin-1-yl-7H-pyrrolo[2,3-d]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration. J Med Chem 51:2147–2157.
  • Davoodnia, A., Bakavoli, M., Moloudi, R., Khashi, M., Tavakoli-Hoseini, N. (2010). 7-deazapurines: synthesis of new pyrrolo[2,3-d]pyrimidin-4-ones catalyzed by a Brønsted-acidic ionic liquid as a green and reusable catalyst. Chin Chem Lett 21:1–4.
  • DeVita, V. T., Jr., Chu, E. (2008). A history of cancer chemotherapy. Cancer Res 68:8643–8653.
  • Gangjee, A., Kurup, S., Ihnat, A. M., Thorpe, E. J., Shenoy, S. S. (2010). Synthesis and biological activity of N(4)-phenylsubstituted-6-(2,4-dichloro phenylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as vascular endothelial growth factor respector-2 inhibitors and antiangiogenic and antitumor agents. Bioorg Med Chem 18:3575–3587.
  • Gangjee, A., Namjoshi, O. A., Yu, J., Ihnat, M. A., Thorpe, J. E., Warnke, L. A. (2008). Design, synthesis, and biological evaluation of substituted pyrrolo[2,3-d]pyrimidines as multiple receptor tyrosine kinase inhibitors and antiangiogenic agents. Bioorg Med Chem 16:5514–5528.
  • Grem, J. L. (1990). Fluorinated pyrimidines. In: Chabner, B. A., Collins, J. M. (Eds.), Cancer chemotherapy: principles and practice (pp 180–224). Philadelphia, Pennsylvania, USA: Lippincott.
  • Gibson, C. L., La Rosa, S., Ohta, K., Boyle, P. H., Leurquin, F., Lemaçon, A., et al. (2004). The synthesis of 7-deazaguanines as potential inhibitors of guanosine triphosphate cyclohydrolase I. Tetrahedron 60:943–959.
  • Habib, N. S., Soliman, R., El-Tombary, A. A., El-Hawash, S. A., Shaaban, O. G. (2007). Synthesis of thiazlo[4,5-d]pyrimidine derivatives as potential antimicrobial agents. Arch Pharm Res 30:1511–1520.
  • Herdewijn, P. A. M. M. (1994). 5-substituted-2′-deoxyuridines as anti-HSV-1 agents: synthesis and structure activity relationship. Antivir Chem Chemother 5:131–146.
  • Hildick, B. G., Shaw, G. (1971). Purines, pyrimidines, and imidazoles. Part XXXVII. Some new syntheses of pyrazolo[3,4-d]pyrimidines, including allopurinol. J Chem Soc 9:1610–1613.
  • Jung, M. H., Kim, H., Choi, W. K., El-Gamal, M. I., Park, J. H., Yoo, K. H., et al. (2009). Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line. Bioorg Med Chem Lett 19:6538–6543.
  • Kemnitzer, W., Sirisoma, N., May, C., Tseng, B., Drewe, J., Cai, S. X. (2009). Discovery of 4-anilino-N-methylthieno[3,2-d]pyrimidines and 4-anilino-N-methylthieno[2,3-d] pyrimidines as potent apoptosis inducers. Bioorg Med Chem Lett 1:3536–3540.
  • Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 16:55–63.
  • Mousavi, S. H., Tavakkol-Afshari, J., Brook, A., Jafari-Anarkooli, I. (2009). Role of caspases and Bax protein in saffron-induced apoptosis in Mcf-7 cells. Food Chem Toxicol 47:1909–1913.
  • Mousavi, S. H., Tayarani-Najaran, Z., Hersey, P. (2008). Apoptosis, from signaling pathways to therapeutic tools. Iran J Basic Med Sci 11:121–142.
  • Pudlo, J. S., Reza Nassiri, M., Kern, E. R., Wotring, L. L., Drach, J. C., Townsen, L. B. (1990). Synthesis, antiproliferative, and antiviral activity of certain 4-substituted and 4,5-disubstituted 7-[1,3-dihydroxy-2-propoxymethyl]pyrrolo[2,3-d]pyrimidines. J Med Chem 33:1984–1992.
  • Schilsky, R. L. (1992). Antimetabolites. In: Perry, M. C. (Ed.), The chemotherapy source book (pp 301–315). Baltimore, Maryland, USA: Williams & Wilkins.
  • Sharma, P., Kumar, A., Sharma, M. (2006). Synthesis and QSAR studies on 5-[2-(2-methylprop1-enyl)-1H benzimidazol-1yl]-4,6-diphenyl-pyrimidin-2-(5H)-thione derivatives as antibacterial agents. Eur J Med Chem 41:833–840.
  • Swayze, E. E., Shannon, W. M., Buckheit, R. W., Wotring, L. L., Drach, J. C., Townsend, L. B. (1992). Synthesis, antiproliferative, and antiviral evaluation of certain acyclic 6-substituted pyrrolo[2,3-d]-pyrimidine nucleoside analogs related to sangivamycin and toyocamycin. Nucleosides Nucleotides 118:1507–1527.
  • Tayarani-Najaran, Z., Mousavi, S. H., Asili, J., Emami, S. A. (2010). Growth-inhibitory effect of Scutellaria lindbergii in human cancer cell lines. Food Chem Toxicol 48:599–604.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.